Unusual Machines Inc. Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Unusual Machines Inc. Common Stock trades at $17.05 (market cap $885.73M), while State Street SPDR S&P Biotech ETF trades at $147.16 (market cap $10.05B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 11.3× Unusual Machines Inc. Common Stock's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Unusual Machines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Unusual Machines Inc. Common Stock for 0 Days and State Street SPDR S&P Biotech ETF for 39 Days on average.
| UMAC | XBI | |
|---|---|---|
Market Cap | $885.73M | $10.05B |
Volume | 3,688,533 | 10,367,649 |
Sector | Technology | Broad Market / Factor |
52-Week High | $34.06 | $169.55 |
52-Week Low | $7.76 | $107.32 |
Typical Hold Time | 0 Days | 39 Days |
Enterprise Value | $572.51M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $146.8, down 3.04% today amid a bearish technical signal. The ETF's modified equal-weight structure provides exposure to over 150 biotech names, benefiting from M&A activity and positive clinical catalysts. Recent news highlights a 76% prior-year rally and optimism around cancer vaccine breakthroughs from Merck and Moderna. However, the ETF carries higher volatility and expense ratios compared to broader healthcare funds.
Outlook remains mixed with technical indicators bearish but fundamental catalysts present. Investment opportunity lies in targeted biotech exposure and sector innovation, though risks include high volatility, regulatory uncertainty, and reliance on clinical trial successes. Analyst consensus is neutral with 100% hold rating, suggesting cautious optimism amid recent price declines.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.
Read more on UMAC →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →